Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality
- PMID: 30481669
- PMCID: PMC7125534
- DOI: 10.1016/j.jcrc.2018.11.013
Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality
Abstract
Purpose: While most influenza patients have a self-limited respiratory illness, 5-10% of hospitalized patients develop severe disease requiring ICU admission. The aim of this study was to identify influenza-specific factors associated with ICU admission and mortality. Furthermore, influenza-specific pulmonary bacterial, fungal and viral co-infections were investigated.
Methods: 199 influenza patients, admitted to two academic hospitals in the Netherlands between 01-10-2015 and 01-04-2016 were investigated of which 45/199 were admitted to the ICU.
Results: A history of Obstructive/Central Sleep Apnea Syndrome, myocardial infarction, dyspnea, influenza type A, BMI > 30, the development of renal failure and bacterial and fungal co-infections, were observed more frequently in patients who were admitted to the ICU, compared with patients at the normal ward. Co-infections were evident in 55.6% of ICU-admitted patients, compared with 20.1% of patients at the normal ward, mainly caused by Staphylococcus aureus, Streptococcus pneumoniae, and Aspergillus fumigatus. Non-survivors suffered from diabetes mellitus and (pre-existent) renal failure more often.
Conclusions: The current study indicates that a history of OSAS/CSAS, myocardial infarction and BMI > 30 might be related to ICU admission in influenza patients. Second, ICU patients develop more pulmonary co-infections. Last, (pre-existent) renal failure and diabetes mellitus are more often observed in non-survivors.
Keywords: Bacterial; Co-infections; Fungal; ICU admission; ICU mortality; Influenza virus; Risk factors; Viral.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Subjects hospitalized with the 2009 pandemic influenza A (H1N1) virus in a respiratory infection unit: clinical factors correlating with ICU admission.Respir Care. 2014 Oct;59(10):1560-8. doi: 10.4187/respcare.03049. Epub 2014 Aug 12. Respir Care. 2014. PMID: 25118307
-
Influenza and associated co-infections in critically ill immunosuppressed patients.Crit Care. 2019 May 2;23(1):152. doi: 10.1186/s13054-019-2425-6. Crit Care. 2019. PMID: 31046842 Free PMC article.
-
Influenza co-infection associated with severity and mortality in COVID-19 patients.Virol J. 2021 Jun 14;18(1):127. doi: 10.1186/s12985-021-01594-0. Virol J. 2021. PMID: 34127006 Free PMC article.
-
Invasive pulmonary aspergillosis in patients with influenza infection: A retrospective study and review of the literature.Clin Respir J. 2019 Apr;13(4):202-211. doi: 10.1111/crj.12995. Epub 2019 Mar 18. Clin Respir J. 2019. PMID: 30661296 Review.
-
Influenza Infections and Emergent Viral Infections in Intensive Care Unit.Semin Respir Crit Care Med. 2019 Aug;40(4):488-497. doi: 10.1055/s-0039-1693497. Epub 2019 Oct 4. Semin Respir Crit Care Med. 2019. PMID: 31585475 Free PMC article. Review.
Cited by
-
Staphylococcus aureus Arsenal To Conquer the Lower Respiratory Tract.mSphere. 2021 May 19;6(3):e00059-21. doi: 10.1128/mSphere.00059-21. mSphere. 2021. PMID: 34011681 Free PMC article. Review.
-
Epidemiology of fungal infection in COVID 19 in Spain during 2020 and 2021: a nationwide study.Sci Rep. 2024 Mar 3;14(1):5203. doi: 10.1038/s41598-024-54340-1. Sci Rep. 2024. PMID: 38433130 Free PMC article.
-
A New Device for Remote Monitoring of Vital Parameters in Acromegalic Patients: Pilot Study.Endocr Metab Immune Disord Drug Targets. 2022;22(14):1410-1415. doi: 10.2174/1871530322666220516161753. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 35578869
-
Concurrent Infection with SARS-CoV-2 and Pneumocystis jirovecii in Immunocompromised and Immunocompetent Individuals.J Fungi (Basel). 2022 May 30;8(6):585. doi: 10.3390/jof8060585. J Fungi (Basel). 2022. PMID: 35736068 Free PMC article. Review.
-
Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and community-acquired pneumonia: A prospective observational study.Curr Med Mycol. 2022 Jun;8(2):16-24. doi: 10.18502/cmm.8.2.10328. Curr Med Mycol. 2022. PMID: 36654789 Free PMC article.
References
-
- Metersky M.L., Masterton R.G., Lode H., File T.M., Jr., Babinchak T. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int. J. Infect. Dis. 2012;16(5):e321–e331. - PubMed
-
- Koch RM, Kox M, de Jonge MI, van der Hoeven JG, Ferwerda G, Pickkers P: Patterns in bacterial- and viral-induced immunosuppression and secondary infections in the ICU. Shock 2016. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical